Codon

JULY 27, 2023

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. No longer. ” And a third paper (BOOM!)

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. No longer. ” And a third paper (BOOM!)

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JUNE 26, 2023

For context, the AAV9 that is often used in gene therapies has a packaging limit of 4,700 DNA bases.) Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. “Anyone with a few years of molecular biology training could do this if so inclined.”

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

For context, the AAV9 that is often used in gene therapies has a packaging limit of 4,700 DNA bases.) Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. “Anyone with a few years of molecular biology training could do this if so inclined.”

DNA 52

DNA Therapies Engineering Clinical Trials 52

Agency IQ

JANUARY 19, 2024

The final version includes some extensive updates to a 2022 draft revision, to include reduced use of animals in testing and development of these products. In 2022, the newly modified guideline (R2) was published for stakeholder feedback following its endorsement by the ICH Assembly. What has changed since the 2022 draft version?

Virus 40

Virus Science Production FDA 40

Drug Target Review

FEBRUARY 19, 2025

If the data package (including safety) is well thought out and developed from the beginning, regulations can be a support to frame the development journey. Cedrone joined Catalent in 2022, bringing with him 18 years of experience in biotech, including key roles at Lysogene SA and Cellectis SA.

Therapies 59

Therapies Molecular Biology Regulations Packaging 59